1. Zaghloul, M.S., A. Nasr, M. Tolba, A. Refaat and A. Youssef et al., 2022. Hypofractionated radiation therapy for diffuse intrinsic pontine glioma: A noninferiority randomized study including 253 children. Int. J. Radiat. Oncol. Biol. Phys., 113: 360-368.
   CrossRef  |  Direct Link  |  
2. Lazow, M.A., C. Fuller, M. DeWire, A. Lane and P. Bandopadhayay et al., 2022. Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG registry. Neuro-Oncology, 24: 821-833.
   CrossRef  |  Direct Link  |  
3. Elhemaly, A., M.S. Zaghloul, S. Ahmed, H. Taha and A. Refaat et al., 2021. Prognostic factors and outcome of pineoblastoma: 10 years single-center experience. J. Egypt. Nat. Canc Inst., Vol. 33. 10.1186/s43046-021-00083-3.
   CrossRef  |  Direct Link  |  
4. Bishr, M.K., M.S. Zaghloul, C. Elmaraghi, A. Galal and M.S. Abdelaziz et al., 2021. The radiotherapy utilization rate in pediatric tumors: An analysis of 13,305 patients. Radiother. Oncol., 154: 220-226.
   CrossRef  |  Direct Link  |  
5. Amer, N., H. Taha, D. Hesham, N. Al-Shehaby and A. Mosaab et al., 2021. Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors. J. Neurooncol., 152: 67-78.
   CrossRef  |  Direct Link  |  
6. van Heerden, J., M. Zaghloul, A. Neven, T. de Rojas and J. Geel et al., 2020. Pediatric oncology clinical trials and collaborative research in Africa: Current landscape and future perspectives. JCO Global Oncol., 6: 1264-1275.
   CrossRef  |  Direct Link  |  
7. Santoni, M., D.Y.C. Heng, G. Aurilio, A. Iozzelli and L. Servi et al., 2020. Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in renal cell carcinoma. Curr. Drug Targets, 21: 416-423.
   CrossRef  |  Direct Link  |  
8. Nakhla, S., A. Rahawy, M. Abd El Salam, T. Shalaby, M. Zaghloul and E. El-Abd, 2020. Radiosensitizing and phototherapeutic effects of AuNPs are mediated by differential noxa and bim gene expression in MCF-7 breast cancer cell line. IEEE Trans. Nanobiosci., 20: 20-27.
   CrossRef  |  Direct Link  |  
9. Mosaab, A., M. El-Ayadi, E.N. Khorshed, N. Amer and A. Refaat et al., 2020. Histone H3K27M mutation overrides histological grading in pediatric gliomas. Sci. Rep., Vol. 10. 10.1038/s41598-020-65272-x.
   CrossRef  |  Direct Link  |  
10. Elmaraghi, C., M.K. Bishr, A.G. Mousa, S. Ahmed and A. Refaat et al., 2020. Pediatric low grade focal brainstem glioma: Outcomes of different treatment strategies and prognostic factors. Future Oncol., 16: 2401-2410.
    CrossRef  |  Direct Link  |  
11. Elghazawy, H., J. Bakkach, M.S. Zaghloul, A. Abusanad and M.M. Hussein et al., 2020. Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol., 16: 2551-2567.
    CrossRef  |  Direct Link  |  
12. Anacak, Y., E. Zubizarreta, M. Zaghloul, S. Laskar and J. Alert et al., 2020. The practice of paediatric radiation oncology in low- and middle-income countries: Outcomes of an international atomic energy agency study. Clin. Oncol., 33: E211-E220.
    CrossRef  |  Direct Link  |  
13. Mousa, A.G., M.K. Bishr, L. Mula-Hussain and M.S. Zaghloul, 2019. Is economic status the main determinant of radiation therapy availability? The Arab world as an example of developing countries. Radiother. Oncol., 140: 182-189.
    CrossRef  |  Direct Link  |  
14. Rosenblatt, E., R.R. Prasad, K. Hopkins, A. Polo and N. Ndlovu et al., 2018. Africa radiation oncology network (AFRONET): An IAEA telemedicine pilot project. J. Int. Soc. Telemed. Ehealth, Vol. 6. 10.29086/JISfTeH.6.e6.
    CrossRef  |  Direct Link  |  
15. Bishr, M.K. and M.S. Zaghloul, 2018. Radiation therapy availability in Africa and Latin America: Two models of low and middle income countries. Int. J. Radiat. Oncol. Biol. Phys., 102: 490-498.
    CrossRef  |  Direct Link  |  
16. Zaghloul, M.S. and T.M. Zaghloul, 2017. Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder. J. Egypt. Natl. Cancer Inst., 10.1016/j.jnci.2017.08.002.
    CrossRef  |  Direct Link  |  
17. Baumann, B.C., P. Sargos, L.J. Eapen, J.A. Efstathiou and A. Choudhury et al., 2017. The rationale for post-operative radiation in localized bladder cancer. Bladder Cancer, 3: 19-30.
    CrossRef  |  Direct Link  |  
18. Anacak, Y., M. Zaghloul and S. Laskar, 2017. Pediatric Radiation Oncology. In: Radiotherapy in Cancer Care: Facing the Global Challenges, Rosenblatt, E. and E. Zubizaretta (Eds.). International Atomic Energy Agency, Vienna, Austria, ISBN: 978-92-0-115013-4, pp: 325-338.
19. Ahmed, G., M. Zamzam, M.S. Zaghloul, A. Kamel and R. Soliman et al., 2017. Outcome of resectable pediatric Ewing sarcoma of the ribs. J. Egypt. Natl. Cancer Inst., 29: 99-104.
    CrossRef  |  Direct Link  |  
20. Zaghloul, M.S., M. Tolba, M.S. El Kady, M. Ezz Eldin, A. Amin, A.G. Mousa and M.S. Bakery, 2016. Simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) for the whole pelvis did not lead to significantly higher toxicity rates than prostate alone IMRT in prostate cancer patients. Clin. Oncol., Vol. 1. .
    Direct Link  |  
21. Zaghloul, M.S., J.P. Christodouleas, A. Smith, A. Abdalla and H. William et al., 2016. Adjuvant sandwich chemotherapy and radiation versus adjuvant chemotherapy alone for locally advanced bladder cancer. Int. J. Radiat. Oncol. Biol. Phys., 96: S94-S94.
    CrossRef  |  Direct Link  |  
22. Zaghloul, M.S., J.P. Christodouleas, A. Smith, A. Abdalla and H. William et al., 2016. A randomized clinical trial comparing adjuvant radiation versus chemo-RT versus chemotherapy alone after radical cystectomy for locally advanced bladder cancer. J. Clin. Oncol., 34: 356-356.
    CrossRef  |  Direct Link  |  
23. Zaghloul, M.S., E. Eldebawy, S. Ahmed, H. Ammar and E. Khalil et al., 2016. Does primary tumor volume predict the outcome of pediatric nasopharyngeal carcinoma?: A prospective single-arm study using neoadjuvant chemotherapy and concomitant chemotherapy with intensity modulated radiotherapy. Asia-Pac. J. Clin. Oncol., 12: 143-150.
    CrossRef  |  PubMed  |  Direct Link  |  
24. Zaghloul, M.S., 2016. The optimal dose of hypofractionated radiotherapy in diffuse intrinsic pontine glioma. Pediatr. Blood Cancer, 63: 948-948.
    CrossRef  |  PubMed  |  Direct Link  |  
25. Zaghloul, M.S., 2016. Single pediatric neuro-oncology center may make difference in low/middle-income countries. Child's Nerv. Syst., 32: 241-242.
    CrossRef  |  PubMed  |  Direct Link  |  
26. Zaghloul, M.S., 2016. Pediatric Neuro-Oncology in Low-/Middle-Income Countries. In: Neuro-Oncology-Newer Developments, Agrawal, A. (Ed.). InTech Publisher, Rijeka, Croatia, ISBN: 978-953-51-2426-9, pp: 447-475.
27. Ezzat, S., M. Kamal, N. El-Khateeb, M. El-Beltagy and H. Taha et al., 2016. Pediatric brain tumors in a low/middle income country: Does it differ from that in developed world? J. Neuro-oncol., 126: 371-376.
    CrossRef  |  PubMed  |  Direct Link  |  
28. El Beltagy, M.A., M. Reda, A. Enayet, M.S. Zaghloul and M. Awad et al., 2016. Treatment and outcome in 65 children with optic pathway gliomas. World Neurosurg., 89: 525-534.
    CrossRef  |  PubMed  |  Direct Link  |  
29. Zekri, W., D. Yehia, M.M. Elshafie, M.S. Zaghloul and N. El-Kinaai et al., 2015. Bilateral clear cell sarcoma of the kidney. J. Egypt. National Cancer Inst., 27: 97-100.
    CrossRef  |  PubMed  |  Direct Link  |  
30. Zaghloul, M.S., 2015. Has hypofractionated radiotherapy become the standard of care in pediatric DIPG? Child's Nerv. Syst., 31: 1221-1222.
    CrossRef  |  PubMed  |  Direct Link  |  
31. Sidhom, I., E.E. Nadi, H. Taha, N. Elkinaai and M.S. Zaghloul et al., 2015. Clinical significance of anaplasia in childhood rhabdomyosarcoma. J. Egypt. National Cancer Inst., 27: 83-89.
    CrossRef  |  PubMed  |  Direct Link  |  
32. Fawzy, M., M. El-Beltagy, M.E. Shafei, M.S. Zaghloul, N.A. Kinaai, A. Refaat and S. Azmy, 2015. Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression. Oncol. Lett., 9: 907-911.
    CrossRef  |  PubMed  |  Direct Link  |  
33. ElZomor, H., H. Taha, A. Aleieldin, R. Nour and M.S. Zaghloul et al., 2015. High risk retinoblastoma: Prevalence and success of treatment in developing countries. Ophthalmic Genet., 36: 287-289.
    CrossRef  |  PubMed  |  Direct Link  |  
34. Zekri, W., A.S. Alfaar, D. Yehia, M.M. Elshafie and M.S. Zaghloul et al., 2014. Clear cell sarcoma of the kidney: Patients' characteristics and improved outcome in developing countries. Pediatr. Blood Cancer, 61: 2185-2190.
    CrossRef  |  Direct Link  |  
35. Zaghloul, M.S., E. Eldebawy, S. Ahmed, A.G. Mousa and A. Amin et al., 2014. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A randomized controlled trial. Radiother. Oncol., 111: 35-40.
    CrossRef  |  PubMed  |  Direct Link  |  
36. Zaghloul, M.S., 2014. More effort is needed to improve the practice of radiotherapy in Africa. Clin. Oncol., 26: 730-731.
    CrossRef  |  PubMed  |  Direct Link  |  
37. Zaghloul, M.S., 2013. Intensity modulated radiotherapy (IMRT) for pediatric cancer patients: The advantage and fear of second malignant neoplasm. J. Egypt. National Cancer Inst., 25: 1-3.
    CrossRef  |  PubMed  |  Direct Link  |  
38. Rahman, H.A., M. Sedky, I. Mohsen, H. Taha and I. Loaye et al., 2013. Outcome of pediatric parameningeal rhabdomyosarcoma. The children cancer hospital, Egypt, experience. J. Egypt. National Cancer Inst., 25: 79-86.
    CrossRef  |  PubMed  |  Direct Link  |  
39. Nadi, E.E., E.A. Moussa, W. Zekri, H. Taha and A. Yones et al., 2013. Outcome of rhabdomyosarcoma in first year of life: Children's cancer hospital 57357 Egypt. Sarcoma, Vol. 2013. 10.1155/2013/439213.
    CrossRef  |  PubMed  |  Direct Link  |  
40. Moussa, E., M. Fawzy, A. Younis, M.E. Shafei and M.S. Zaghloul et al., 2013. Combined treatment strategy and outcome of high risk neuroblastoma: Experience of the children's cancer hospital-Egypt. J. Cancer Ther., 4: 1435-1442.
    CrossRef  |  Direct Link  |  
41. Aly, A.M., E. Eldebawy, S. Ahmed, A. Refaat and E. Attala et al., 2013. Can conventional magnetic resonance imaging predict survival in pediatric diffuse intrinsic pontine glioma? A single institution experience. Egypt. J. Radiol. Nucl. Med., 44: 871-878.
    CrossRef  |  Direct Link  |  
42. Zaghloul, M.S., E. Eldebawy, E. Attalah, S. Ahmed, M Nazmy and H.A. Anin, 2012. Supine craniospinal irradiation in children: patient position modification, dose uniformity and early adverse effects. Gulf. J. Oncol., 2012: 7-15.
    Direct Link  |  
43. Zaghloul, M.S., 2012. Re-evaluation of the value of adjunctive modern radiotherapy in muscle-invasive bladder cancer. J. Solid Tumors, 2: 1-3.
    CrossRef  |  Direct Link  |  
44. Zaghloul, M.S., 2012. Bladder cancer and schistosomiasis. J. Egypt. National Cancer Inst., 24: 151-159.
    CrossRef  |  Direct Link  |  
45. Zaghloul, M.S. and I. Gouda, 2012. Schistosomiasis and bladder cancer: Similarities and differences from urothelial cancer. Expert Rev. Anticancer Ther., 12: 753-763.
    CrossRef  |  PubMed  |  Direct Link  |  
46. Zaghloul, M.S. and I. Gouda, 2012. Bladder Cancer and Schistosomiasis: Is There a Difference for the Association? In: Bladder Cancer - From Basic Science to Robotic Surgery. Canda, A.E. (Ed.)., InTech, Rijeka, Croatia, pp 195-218.
    CrossRef  |  Direct Link  |  
47. Wolpert, B.J., S. Amr, A.S. Doa`a, S. Ezzat, I. Gouda, I. Loay and M.S. Zaghloul et al 2012. Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt. Urol. Oncol.: Semin. Original Invest., 30: 841-847.
    CrossRef  |  
48. Eldesoky, I., E.M. Attalla, W.M. Elshemey and M.S. Zaghloul, 2012. A comparison of three commercial IMRT treatment planning systems for selected pediatric cases. J. Appl. Clin. Med. Phys., 13: 124-135.
    CrossRef  |  Direct Link  |  
49. Zaghloul, M.S., 2011. Joint genitourinary cancer symposium between Egyptian and American centers. Expert Rev. Anticancer Ther., 11: 697-699.
    PubMed  |  
50. Goerlitz, D., M. El-Daly, M. Abdel-Hamid, D.A. Saleh and M.S. Zaghloul et al., 2011. GSTM1, GSTT1 null variants and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt. Cancer Epidemiol. Biomarkers Prev., 20: 1552-1554.
    CrossRef  |  
51. Eldebawy, E., E. Attalla, I. Eldesoky and M.S. Zaghloul, 2011. Geometrical uncertainty margins in 3D conformal radiotherapy in the pediatric age group. J. Egypt. Nat.Cancer Inst., 23: 55-60.
    CrossRef  |  Direct Link  |  
52. El-Hafez, A.I., H.A. Shousha, M.S. Zaghloul and M.A. Abou Zeid, 2011. Influence of field size, depth, nominal dose rate and stem length on ion recombination correction factor in therapeutic photon beam. Am. J. Sci., 7: 206-213.
    Direct Link  |  
53. Ahmed, S., M. Zaghloul and E. Eldebawy, 2011. 4118 POSTER Prospective Randomized Trial of Hypofractionated Conformal Radiotherapy for Pediatric Diffuse Pontine Glioma. Eur. J. Cancer, 47: S289-S289.
    CrossRef  |  
54. Abou-elenein, H.S., E.M. Attalla, H. Ammar, I. Eldesoky, M. Farouk and M.S. Zaghloul, 2011. Megavoltage cone beam computed tomography: Commissioning and evaluation of patient dose. J. Med. Phys., 36: 205-212.
    Direct Link  |  
55. Zaghloul, M.S., R. Boutrus, H. El-Hossieny, Y.A. Kader, I. El-Attar and M. Nazmy, 2010. A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. Int. J. Clin. Oncol., 15: 382-389.
    PubMed  |  
56. Zaghloul, M.S., A.G. Mousa, E. Eldebawy, E. Attalla, H. Shafik and S. Ezzat, 2010. Comparison of electronic portal imaging and cone beam computed tomography for position verification in children. Clin. Oncol. (R. Coll. Radiol.), 22: 850-861.
    PubMed  |  
57. Zaghloul, M.S., 2010. The need to revisit adjuvant and neoadjuvant radiotherapy in bladder cancer. Expert Rev. Anticancer Ther., 10: 1527-1528.
    CrossRef  |  
58. Zaghloul, M.S., 2010. Radiotherapy for Locally Advanced Bladder Cancer (Chapter 4). In: In: Bladder Cancer: Etymology, Diagnosis and Treatments, Nilsson, W.E. (Ed.)., Nova Publisher, London, ISBN: 978-1-61728-002-3, pp: 81-118.
59. Zaghloul, M.S., 2010. Adjuvant and neoadjuvant radiotherapy for bladder cancer: Revisited. Future Oncol., 6: 1177-1191.
    Direct Link  |  
60. Zaghloul, M.S. and A.G. Mousa, 2010. Trimodality treatment for bladder cancer: Does modern radiotherapy improve the end results?. Expert Rev. Anticancer Ther., 10: 1933-1944.
    PubMed  |  
61. Wolpert, B.J., S. Amr, S. Ezzat, D. Saleh and I. Gouda et al., 2010. Estrogen exposure and bladder cancer risk in Egyptian women. Maturitas, 67: 353-357.
    PubMed  |  
62. Zaghloul, M.S., 2009. The first children's cancer hospital, Egypt international scientific conference. Expert Rev. Anticancer Ther., 9: 1435-1437.
    PubMed  |  
63. Zaghloul, M.S., A. Nouh, M. Moneer, M. El-Baradie, M. Nazmy and A. Younis, 2008. Time-trend in epidemiological and pathological features of schistosoma-associated bladder cancer. J. Egypt. Natl. Cancer Inst., 20: 168-174.
    PubMed  |  
64. Zaghloul, M.S., 2008. Radiation oncology facilities in Africa: What is the most important equipment, staffing or guidelines?. Int. J. Radiat. Oncol. Biol. Phys., 71: 1600-1601.
    PubMed  |  
65. Zaghloul, M.S., 2008. Does schistosoma-associated bladder cancer differ from urothelial cancer?. Proof from the laboratory and clinic. Cancer Genet. Cytogenet, 180: 160-162.
    PubMed  |  
66. Khaled, H., M.E. Emara, R.M. Gaafar, O. Mansour, A.A. Warith, M.S. Zaghloul and O. El-Malt, 2008. Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: A phase II trial. Urol. Oncol., 26: 133-136.
    PubMed  |  
67. Felix, A.S., A.S. Soliman, H. Khaled, M.S. Zaghloul and M. Banerjee et al., 2008. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control, 19: 421-429.
    PubMed  |  
68. Zaghloul, M.S., S.A. El-Badawi and H.A. Elbaky, 2007. Professor Hassan K. Awwad; The Father of radiation oncology and radiobiology in Egypt and the Arab world, His good deeds last forever and inspire us for the future. J. Egypt. Natl. Cancer Inst., 19: 1-2.
    PubMed  |  
69. Zaghloul, M.S., M. El-Baradie, Nouh, S. Abdel-Fatah, A. Taher and M. Shalaan, 2007. Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J. Oncol., 1: 47-54.
    PubMed  |  
70. Zaghloul, M.S., 2007. Re: Patterns of initial transitional cell recurrence in patients after cystectomy. J. Urol., Vol. 178. .
    PubMed  |  
71. Zaghloul, M.S. and S.A. El-Badawy, 2007. A Tribute to the father of radiation oncology and radiobiology in Egypt and the Arab world: Professor Hassan K. Awwad. Int. J. Radiat. Oncol. Biol. Phys., 69: 2-3.
    CrossRef  |  
72. Murthy, V. and M.S. Zaghloul, 2007. Adjuvant radiotherapy in bladder cancer: Time to take a fresh look?. Urol. Oncol., 25: 353-354.
    CrossRef  |  
73. Hashim, M., M. Sayed, F.F. Ibrahim, M.S. Zaghloul and S. El-Shazly, 2007. Molecular detection of uroplakin II in the peripheral blood of patients with urothelial carcinoma of the urinary bladder. Arab J. Lab. Med., 2: 267-280.
74. Abdel-Hafez, A.I., M.B. Afifi, M.S. Zaghloul and M.A. Abou Zeid, 2007. Nominal Dose Rate and Stem Length Dependence of Polarity Correction Factor of PTW30006 Ionization Chamber Used in 6 and 10 MV Photon Beams. Egypt. J. Biophys., 13: 71-81.
75. Zaghloul, M.S., H.M. Khaled, M. Lotayef and H. William, 2006. Adjuvant chemoradiotherapy after radical cystectomy in advanced high risk bladder cancer: A prospective randomized trial. ASCO Annu. Meeting Proc., Vol. 24. .
    Direct Link  |  
76. Zaghloul, M.S., A. Nouh, M. Nazmy, S. Ramzy, A.S. Zaghloul, M.A. Sedira and E. Khalil, 2006. Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients. Urol. Oncol., 24: 13-20.
    PubMed  |  
77. Zaghloul, M.S., 2006. Adjuvant radiation therapy for locally advanced bladder cancer. Touchbriefings, US Oncol. Dis., 2: 86-89.
78. Ebeid, E.N., M. Zaghloul and M. Khairy, 2006. Clinical outcome of pediatric Hodgkin's disease in upper Egypt. ASCO Annu. Meeting Proc., Vol. 24. .
    Direct Link  |  
79. Zaghloul, M.S., 2005. Adjuvant radiation therapy for muscle-invasive bladder cancer. Tunis. Med., 12: 92-93.
    PubMed  |  
80. Khaled, H.K., N.G. El-Mawl, M.R. Hamza, M. El-Serafi and M.S. Zaghloul et al., 2005. Role of chemotherapy in advanced squamous cellcarcinoma of the bladder. Ann. Oncol., 5: 1-200.
81. El-Sebaie, M., M.S. Zaghloul, G. Howard and A. Mokhtar, 2005. Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: A review of etiological features, natural history and management. Int. J. Clin. Oncol., 10: 20-25.
    PubMed  |  
82. Cerciello, F., B. Hofstetter, S.A. Fatah, M. Zaghloul and B. Odermatt et al., 2005. G(2)/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 62: 1390-1398.
    CrossRef  |  
83. Zaghloul, M.S., S.A. Aziz, A. Nouh, T.Z. Mohran, S. Shazely and A. Saber, 2003. Primary adenocarcinoma of the urinary bladder: Risk factors and value of postoperative radiotherapy. J. Egypt. Natl. Cancer Inst., 15: 193-200.
    Direct Link  |  
84. Zaghloul, M.S, M.M. Elmongi, A.A. Hassan and B. Elgendi, 2003. Prognostic factors for bone-only metastasis in breast cancer patients. Proc. Am. Soc. Clin. Oncol., Vol. 22. .
85. Saber, R.A., T.Z. Mahran, K.A. Enin, M.S. Zaghloul and S. Shehata, 2003. Response of skeletal metastases to systemic chemotherapy in patients with breast cancer. El-Minia Med, Bull., 14: 126-139.
86. Ebeid, E.N., M.S. Zaghloul, A. Khairy, M. Zamzam, I. Sidhom and A. Saber, 2003. New therapeutic strategies in pediatric brain gliomas. Proc. Am. Soc. Clin. Oncol., Vol. 22. .
87. Zaghloul, M.S., T.Z. Mohran, R.A. Saber and N. Agha, 2002. Post operative radiotherapy in bladder cancer. J. Egypt. Natl. Cancer Inst., 14: 161-168.
    Direct Link  |  
88. Zaghloul, M.S., O.A. Khalil, H.S. Abdelghany and I.M. Ahmed, 2002. Role of helical computed tomography in staging of urinary bladder cancer. Egypt. J. Radiol. Nucl. Med., 33: 281-289.
89. Khaled, H.M., M.S. Zaghloul, M. Ghoneim, R.A. Saber and M. Manie et al., 2002. A randomized phase III study of neoadjuvant chemotherapy for invasive bladder cancer with gemcitabine and cisplatin. Proc. Am. Soc. Clin. Oncol., Vol. 21. .
90. Moneer, M., S. Isamail, H. Khaled, M. El-Gantery, M.S. Zaghloul and M. El-Didi, 2001. A new surgical strategy for breast conservation in locally advanced breast cancer that achieves a good locoregional control rate: Preliminary report. Breast, 10: 220-224.
    PubMed  |  
91. Zaghloul, M.S., M. El-Naggar, A. El-Deeb, H. Khaled and N. Mokhtar, 2000. Prognostic implication of apoptesis and angiogenensis cervical uteri cancer. Int. J. Radiat. Oncol. Biol. Phys., 48: 1409-1415.
    PubMed  |  
92. Khaled, H.M., M.R. Hamza, O. Mansour, R. Gaafer and M.S. Zaghloul, 2000. A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bieharzial bladder carcinoma. Eur. J. Cancer, 36: 34-37.
    PubMed  |  
93. khorshid, A.M., N. Hamdy, D.S. Hindawy, M.S. Zaghloul and S. Farrag, 1997. Electomicroscopic study of radiation-induced apoptosis. J. Egypt. Natl. Cancer Inst., 9: 151-157.
94. Zaghloul, M.S., M.H. Hussein, M. El-Naggar, I. El-Attar and G. Emira, 1997. Pathological versus clinical staging for children with Hodgkin's disease. Comparison of long-term results. J. Egypt. Natl. Cancer Inst., 9: 87-96.
95. Zaghloul, M.S., 1996. Distant metastasis from bilharzial bladder cancer. Cancer, 77: 743-749.
    PubMed  |  
96. Abou-Gabal, A., El-Badawy, M.S. Zaghloul, M. Bassiuony, O. El-Hattab and A. El-Arini, 1996. Localized ewing's sarcoma in children results of therapy. J. Egypt. Natl. Cancer Inst., 8: 9-15.
97. Abou-Gabal, A., M.S. Zaghloul, M. El-Naggar and O. El-Hattab, 1996. Long term survivors in childhood rhabdomyosarcoma. Treatment strategy and prognostic factors. J. Egypt. Natl. Cancer Inst., 8: 23-27.
98. Zaghloul, M.S., M.H. Hussein, A.A. Hassan, S.M. Ahmed, A.M.A. Wahab, I. El-Attar and A.A. Moneim, 1995. Prediction of abdominal involvement in children with Hodgkin disease. Med. J. Cairo Univ., 63: 267-273.
99. Hussein, M.H., M.S. Zaghloul, A.A. Hassan, S.M. Ahmed, A.M.A. Wahab, I. El-Attar and H.A. Moneim, 1995. Long term results of paediatric Hodgkin's disease. Med. J. Cairo Univ., 63: 15-26.
100. El-Kalawee, M., M.S. Zaghloul and H. Abdallah, 1995. Combind surgery and radiotherapy as a salvage therapy in the treatment of locoregional recurrence following mastectomy for breast cancer. Med. J. Cairo Univ., 63: 237-244.
101. Abdallah, H., M. Barsoum, M. El-Serafi, A. El-Gayed and I. El-Attar et al., 1995. Long term results of adjuvant chemotherapy in carcinoma of the breast. NCI-Cairo experience. Med. J. Cairo Univ., 63: 115-119.
102. Hussein, M.H., N.A. Wahby, M.S. Zaghloul, A.A. Wahab, M.R. Sakr and Abou-Gabal, 1994. Clinical evaluation of testicular biopsy in long term survivors of Acute lymphoblastic leukaemia. Egypt. J. Hematol., 19: 123-129.
103. Zaghloul, M.S., N.M. Dahaba, A.A. Wahab, M.H. Hussein and M. El-Koutby, 1993. Nasopharyngeal carcinoma in childern and adolescents. Successful role of retrieval therapy. Tumori, 79: 123-127.
     PubMed  |  
104. Zaghloul, M.S., M.J. Dorie and R.F. Kallman, 1993. 1nterleukin 1 modulatory effects on the action of chemotherapeutic drugs and localized irradiation of the lipduodenum and tumor. Int. J. Radiat Oncol. Biol. Phys., 26: 417-425.
     PubMed  |  
105. Ezzat, S., H. Abdallah, M. El-Naggar, A. Zaki and M. Zaghloul, 1993. Preoperative versus postoperative irradiation in locally advanced carcinoma of the rectum. J. Egypt. Nat. Cancer Inst., 6: 55-62.
106. Zaghloul, M.S., H.K. Awwad, H.H. Akoush, S. Omar, O. Soliman and I. El-Attar, 1992. Postoperative radiotherapy of carcinoma in Bilharzial bladder. Improved disease-free survival through improving local control. Int. J. Radiat. Oncol. Biol. Phys., 23: 511-517.
     PubMed  |  
107. Zaghloul, M.S. and T.Y. Khatab, 1992. Dysgerminoma of the ovary. Good prognosis even in advanced stages. Int. J. Radiat. Oncol. Biol. Phys., 24: 161-165.
     PubMed  |  
108. Awwad, H.K., Y. Khafagy, M. Barsoum, S. Ezzat and I. EI-Attar et al., 1992. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumour proliferation. Radiother. Oncol., 25: 261-266.
     PubMed  |  
109. Kallman, R.F., D. Rapacchietta and M.S. Zaghloul, 1991. Schedule dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems. Int. J. Rad. Oncol. Biol. Phys., 20: 227-232.
     PubMed  |  
110. Issa, S., Y. Youssef, B. Anaan, M. EI-Fouly, H. Massoud, M.S. Zaghloul and A. Saleh, 1991. Post-irradiation microbiological changes in DNA. content, antimicrobial sensitivity and some enzyme, activity in cancer bladder patients. J. Egypt. Natl. Cancer Inst., 5: 269-282.
111. Hussein, M.H., N.A. Wahby, M.S. Zaghloul, A.A. Wahab and M.R. Sakr, 1991. Clinical evaluation of testicular biopsy in long-term survivors of Acute lymphoblastic leukaemia. J. Egypt. Med. Assoc., 74: 421-428.
112. Wahab, A.A., M.S. Zaghloul, S. Issa and H. Hussein, 1990. Effect of therapy in neutrophil functions in children with acute lymphoblastic leukaemia. Egypt. J. Haematol., 15: 183-1505.
113. Baky, H.A., M.S. Zaghloul, I. El-Ghoneimy, M. El-Baradie and M. El-Shahawy, 1990. Maxillary sinus tumours, 9 years experience. J. Egypt. Natl. Cancer Inst., 4: 771-779.
114. Akoush, H., M.Y. Zayed, M.S. Zaghloul, M. El-Naggar and H.A. Moneim, 1990. Radiotherapy for nasopharyngeal carcinoma. Results of treatment. Egypt. Med. J., 7: 215-222.
115. Zaghloul, M.S. and T.Y. Khattab, 1989. Dysgerminoma of the ovary. Results of different strategies of treatment and prognostic factors. Ain Shams Med. J., 8: 291-295.
116. Wahab, A.A., M.S. Zaghloul, S.A. Radi, S. Issa, A. Moustafa and H. Hussein, 1989. Factors affecting the state of nutrition in children suffering from malignant tumours. J. Egypt. Natl. Cancer Inst., 4: 333-342.
117. El-Gantiry, M., A. El-Weeshy, H.A. Baky, A. Hassan, M. Zaghloul, H. Akoush and S. El-Badawi, 1989. Results of treatment of, testicular seminoma. 7 years follow-up. Egypt. J. Radiol. Nucl. Med., 7: 167-174.
118. Dorie, M.J., A.C. Allison, M.S. Zaghloul and R.F. Kallman, 1989. Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals. Proc. Soc. Exp. Biol. Med., 191: 23-29.
     PubMed  |  
119. Baky, H.A., O. Abbasy, N.A. Salam, M.S. Zaghloul and H. Akoush, 1989. Radioprotective effect of WR 2721 on oral cavity structures in rats. A histopathological study. J. Egypt. Natl. Cancer Inst., 4: 173-182.
120. Baky, H.A., M.S. Zaghloul, H. Akoush, A. El-Aaser, N.A. Salam, O. Abbasy and R. Ghali, 1989. Evaluation of radioprotective efficiency of the WR 2721 and Thiola on irradiated rat submandibular salivary gland. An enzymatic study. J. Egypt. Natl. Cancer Inst., 4: 235-246.
121. Awwad, H.K., S. El-Badawi, H.A. Baky, M. Zaghloul, K. Osman, H. Akoush and K. Fairchild, 1989. Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer. Evidence of diffusion from urine. Int.J. Radiat. Oncol. Biol., Phys., 16: 1083-1084.
     PubMed  |  
122. Eissa, S., M. Saad, M. Barsoum and S. Omar, 1988. Minimal Breast Cancer. In: In: Breast Cancer, Contesso, G. and S. Ornar (Eds.)., Kopra, London, pp: 154-157.
123. Zaghloul, M.S., S. El-Badawi, S.A. Hadi, A.A. Wahab and R. Hamza et al., 1987. Five-year follow up after central nervous systern prophylaxis in children with Acute lymphoblastic leukaeniia. J. Egypt. Natl. Cancer Inst., 3: 63-70.
124. Zaghloul, M.S., H.K. Awwad, O. Soliman, S. Omar and S. El-Badawi et al., 1986. Postoperative radiotherapy of carcinoma in Bilharzial bladder using a three-fractions per day regimen. Radiat. Oncol., 6: 257-265.
125. Ezzat, S., H. Akoush, M.S. Zaghloul, M.A.A. El-Ella, H.A. Baky, H.A. Moneim and T. Helal, 1986. Results of treatment of solitary plasmacytoma. J. Egypt. Natl. Cancer Inst., 2: 515-521.
126. El-Badawi, S.A., M.S. Barsoum, H. Akoush, H. Abdel-Baky, S. Ezzat, H.A. Moneim and M.S. Zaghloul, 1986. Sequential half body irradiation as systemic treatment of metastatic breast cancer. J. Egypt. Natl. Cancer Inst., 2: 495-500.
127. Barsoum, M., M. El-Serafi, H. Akoush, M.A. Moneim, A. El-Khoudary, S. Ezzat and M. Zaghloul, 1986. Adjuvant therapy after radical mastectomy for T₁ and T₂ breast cancer. A randomized trial between chemotherapy alone and chemotherapy plus radiotherapy. J. Egypt. Natl. Cancer Inst., 3: 335-345.
128. Akoush, H., M. Barsourn, H.A. Baky, S. Ezzat, H. Abdel-Moneim, M.S. Zaghloul and S. El-Badawi, 1986. Clinco-pathological features and results of treatment of malignant thymoma. J. Egypt. Natl. Cancer Inst., 2: 501-506.
129. Akoush, H., H.A. Moneim and M.S. Zaghloul, 1986. Histocytosis-X: Presentation and management. J. Egypt. Natl. Cancer Inst., 2: 507-513.
130. Ezzat, L., S. El-Badawi, R. Harnza, K. EI-Ghamrawy and M.S. Zaghloul et al., 1982. Prophylactic therapy for central nervous system in Acute lymphoblastic leukaemia. Med. J. Cairo. Univ., 50: 39-50.